ArticleJournal of market access & health policy2023

Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement.

Bérengère Macabeo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.